Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
F. Couturaud (Brest, France). Duration of anticoagulant therapy: a change in the paradigm. International Congress 2019 – Update on anticoagulant therapy: controversy and progress

Member's Comments

No comment yet.

Related content which might interest you: Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit? Source: Eur Respir J 2016; 48: 1268-1270 Year: 2016 Systemic treatment: an adjuvant indication? Source: Annual Congress 2004 - Lung metastases Year: 2004 Initial anticoagulant treatment and home treatment of PE Source: ERS Course 2019 - Masterclass in pulmonary embolism Year: 2019 Is there a benefit of an additive standard immunoglobulin therapy for the clinical course of COPD patients under chronic immunosuppressive therapy? Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001 Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Relationship between prior triple therapy use and benefits of budesonide/glycopyrronium/formoterol on exacerbation risk: analysis from ETHOS Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003 Paradoxical response to adequate antituberculosis treatment Source: Eur Respir J 2004; 24: Suppl. 48, 724s Year: 2004 Anticoagulant treatment of venous thromboembolism: established and new oral agents, remaining questions Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism Year: 2014 Update on novel anticoagulants: indications, dosing alternatives and outcomes Source: International Congress 2018 – Pulmonary embolism: what we need to know Year: 2018 Late Breaking Abstract - Severe pneumonia patients may could not benefit from antibiotic combination therapy and non-invasive ventilation(NIV), despite the advanced mode Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017 Year: 2017 Combination therapy in the era of immunotherapy Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Management of bleeding during anticoagulant therapy Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress Year: 2019 Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma? Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009